FT
Fate Therapeutics Inc
🇩🇪XSTU.F6TGermanyHealthcare
€2.04EURdown -0.02 (-0.97%)OpenEnd of day5:10 PM
Price€2.04-0.02 (-0.97%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US31189P1021
- CUSIP
- Not reported
Company
- Employees
- 161
- Headquarters
- San Diego, United States
- CEO
- Dr. Bahram Valamehr M.B.A., Ph.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- -$1.05
- P/E LTM
- -2.58
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $6.49M-23.36%down year on year
- Net income
- -$126M+26.54%up year on year
- Gross margin
- -390.2%+56.67%up year on year
- Free cash flow
- -$105.66M+11.04%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.